Skip to main content

Table 7 Anti-RBD levels by infection:

From: Comparison of the safety and immunogenicity of the BNT-162b2 vaccine and the ChAdOx1 vaccine for solid organ transplant recipients: a prospective study

  

Before propensity score matching

  

After propensity score matching

  
 

Total

n (%)

Breakthrough

n (%)

No breakthrough n (%)

p-value

Breakthrough

n (%)

No breakthrough n (%)

p-value

Post dose-1

Response after dose-1

33.20

41.6

32.3

0.354

27.7

24.6

0.774

Post dose-2

Response after dose-2

70.32

90

68.97

0.159

100

66.6

0.088

Kidney Tx

Post dose-1

Response to dose-1

19.11

25

18.4

0.527

   

Kidney Tx

Post dose-2

Response to dose-2

60.87

80

59.77

0.367

   

Liver Tx

Post dose-1

Response to dose-1

56.99

75

55.2

0.282

   

Liver Tx

Post dose-2

Response to dose-2

84.13

100

82.76

0.311

  Â